In vivo studies in rodents have suggested that A1-adenosine receptor activation in WAT improves glucose tolerance and insulin sensitivity, and its deficiency leads to glucose intolerance and impaired insulin action (60, 62, 102). The gene discussed is INS; the disease is Glucose intolerance.